The Latest Breaking News on Pharma

Pharmacies will be paid thousands more to dispense medicines from July 1 as part of a government funding boost.

Seven new alternatives to the high-cost Humira drug will be available in July. Some will be offered at significantly lower prices, but will patients see big savings?

Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July

Reata CEO Warren Huff says Friedreich's ataxia is "the worst disease." Now, RETA stock investors are watching the long-awaited drug launch.

Zimmer Biomet has confirmed plans to close its factory in Bridgend

Zimmer Biomet in Bridgend has entered into consultation with its staff

Every drug in the market goes through a long journey of tests, each designed to check whether it can treat the disease for which it was created and whether it has any unintended harmful effects. For a long time, the first step of this process was to test the candidate…

The biotech industry is well-positioned for long-term growth thanks to increasing demand for quality healthcare, a rapidly aging population, and rising chronic diseases. Therefore, buying fundamentally strong biotech stocks Entrada Therapeutics (TRDA) and ProQR Therapeutics N.V. (PRQR) could be wise. On the other hand, one should consider selling 4D Molecular…

Owing to the rising prevalence of chronic medical conditions and awareness among the patient population, the medical industry is poised for remarkable growth. Therefore, it could be wise to scoop up the shares of quality medical stocks Medtronic plc (MDT), FONAR Corporation (FONR), and Electromed, Inc. (ELMD), which carry significant…